1. Home
  2. TCRT vs SPHL Comparison

TCRT vs SPHL Comparison

Compare TCRT & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

HOLD

Current Price

$2.98

Market Cap

6.7M

Sector

Health Care

ML Signal

HOLD

Logo Springview Holdings Ltd Class A Ordinary Shares

SPHL

Springview Holdings Ltd Class A Ordinary Shares

HOLD

Current Price

$2.40

Market Cap

5.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCRT
SPHL
Founded
1998
2002
Country
United States
Singapore
Employees
N/A
73
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
5.7M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
TCRT
SPHL
Price
$2.98
$2.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.6K
5.9K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
24.66
N/A
EPS
N/A
N/A
Revenue
$15,900,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$0.35
52 Week High
$5.48
$25.11

Technical Indicators

Market Signals
Indicator
TCRT
SPHL
Relative Strength Index (RSI) 59.23 45.96
Support Level $2.39 $2.46
Resistance Level $3.10 $3.10
Average True Range (ATR) 0.17 0.18
MACD 0.06 -0.02
Stochastic Oscillator 73.38 18.19

Price Performance

Historical Comparison
TCRT
SPHL

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd conducts its operations through its indirect wholly-owned subsidiary, which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of work, including new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment in the development of construction projects. It derives maximum revenue from its Residential Customers.

Share on Social Networks: